BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19959806)

  • 21. The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop.
    Blajchman MA; Carson JL; Eikelboom JW; Heddle NM; Lacroix J; Lauer MS; Platt R; Tilley B; Triulzi D; Vickers AJ; Yusuf S; Glynn S; Mondoro TH; Wagner E
    Transfusion; 2012 Jun; 52(6):1363-78. PubMed ID: 22486525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trials and comparative effectiveness research.
    Hahn OM; Schilsky RL
    J Clin Oncol; 2012 Dec; 30(34):4194-201. PubMed ID: 23071239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Marginal medicine': targeting comparative effectiveness research to reduce waste.
    Hoffman A; Pearson SD
    Health Aff (Millwood); 2009; 28(4):w710-8. PubMed ID: 19556249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A flexible approach to evidentiary standards for comparative effectiveness research.
    Garrison LP; Neumann PJ; Radensky P; Walcoff SD
    Health Aff (Millwood); 2010 Oct; 29(10):1812-7. PubMed ID: 20921480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The whole is greater than the sum of its parts: the anatomy of the Department of Veterans Affairs Medical District 17 Health Services Research and Development Field Program.
    Demakis JG; Turpin RS; Conrad KJ; Stiers WM; Weaver FM; Sinacore JM; Cowper DC; Darcy LA; Huck MN; Friedman BS
    Health Serv Res; 1990 Apr; 25(1 Pt 2):269-85. PubMed ID: 2184151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Closing the information gap: informing better medical decisionmaking through the use of post-market safety and comparative effectiveness information.
    Fox B
    Food Drug Law J; 2012; 67(1):83-101, iii. PubMed ID: 24624650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical issues related to cardiac report cards.
    Nast S; Richard SA; Martin DK
    Can J Cardiol; 2004 Mar; 20(3):325-8. PubMed ID: 15054513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary: Will academia embrace comparative effectiveness research?
    Lauer MS
    Acad Med; 2011 Jun; 86(6):671-3. PubMed ID: 21613887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative-effectiveness research: does it matter?
    Cohen JP
    Clin Ther; 2013 Apr; 35(4):371-9. PubMed ID: 23523048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Framework for assessing governance of the health system in developing countries: gateway to good governance.
    Siddiqi S; Masud TI; Nishtar S; Peters DH; Sabri B; Bile KM; Jama MA
    Health Policy; 2009 Apr; 90(1):13-25. PubMed ID: 18838188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical, legal and ethical issues in critical care.
    Wallace-Barnhill G; Roth MD; Briggs BA; Bastron DR; Barrocas A
    Crit Care Med; 1982 Jan; 10(1):57-61. PubMed ID: 7056060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of comparative effectiveness on U.S. healthcare providers.
    Bigalke JT
    Healthc Financ Manage; 2009 Oct; 63(10):74-8. PubMed ID: 19810656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness research and the chiropractic profession.
    Johnson C
    J Manipulative Physiol Ther; 2010 May; 33(4):243-50. PubMed ID: 20534310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allocating health resources ethically: new roles for administrators and clinicians.
    Veatch RM
    Front Health Serv Manage; 1991; 8(1):3-29, 43-4. PubMed ID: 10112248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.